US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses. Our quality metrics help you find companies that generate superior returns on capital employed.
As of April 29, 2026, Integra LifeSciences Holdings Corporation (IART) trades at a current price of $10.08, representing a 6.15% drop in recent sessions. This analysis looks at key market context, technical levels, and potential near-term scenarios for the medtech name, without providing any investment recommendations. IART’s recent price action has been driven largely by broader sector flows and technical trading dynamics, as no recent earnings data is available for the firm as of this writing.
What market indicators Integra (IART)? (Slides) 2026-04-29 - Stop Loss Levels
IART - Stock Analysis
3202 Comments
1676 Likes
1
Jany
New Visitor
2 hours ago
Too late… oh well.
👍 225
Reply
2
Rheda
Insight Reader
5 hours ago
This sets a high standard.
👍 160
Reply
3
Cyanne
Active Reader
1 day ago
Solid overview without overwhelming with data.
👍 239
Reply
4
Tassia
Active Contributor
1 day ago
The market is stabilizing near key technical zones, offering a foundation for strategic positioning.
👍 295
Reply
5
Captolia
Active Contributor
2 days ago
Everyone should take notes from this. 📝
👍 145
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.